Eric A. Ertel

2.0k total citations
29 papers, 905 citations indexed

About

Eric A. Ertel is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eric A. Ertel has authored 29 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eric A. Ertel's work include Ion channel regulation and function (19 papers), Cardiac electrophysiology and arrhythmias (14 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Eric A. Ertel is often cited by papers focused on Ion channel regulation and function (19 papers), Cardiac electrophysiology and arrhythmias (14 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Eric A. Ertel collaborates with scholars based in Switzerland and United States. Eric A. Ertel's co-authors include Sylvie I. Ertel, Jean‐Paul Clozel, Charles J. Cohen, McHardy M. Smith, Agnès Bénardeau, Michel F. Rossier, M. B. Vallotton, Loı̈c Perchenet, Vivien A. Warren and Thomas Pfeifer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Eric A. Ertel

29 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric A. Ertel Switzerland 17 620 312 287 117 75 29 905
Gregory H. Hockerman United States 23 1.5k 2.3× 717 2.3× 510 1.8× 185 1.6× 84 1.1× 50 1.9k
Donald H. Jenkinson United Kingdom 13 473 0.8× 240 0.8× 157 0.5× 79 0.7× 20 0.3× 19 592
Theresa A. Kuntzweiler United States 17 1.2k 1.9× 147 0.5× 106 0.4× 149 1.3× 83 1.1× 23 1.4k
László Kovács Hungary 17 567 0.9× 233 0.7× 214 0.7× 222 1.9× 25 0.3× 41 981
Jon T. Sack United States 17 656 1.1× 303 1.0× 223 0.8× 51 0.4× 9 0.1× 43 853
Jeff S. McDermott United States 15 694 1.1× 218 0.7× 368 1.3× 55 0.5× 8 0.1× 27 938
K Gietzen Germany 14 639 1.0× 162 0.5× 92 0.3× 52 0.4× 21 0.3× 28 887
Francisco Fernández-Belda Spain 14 688 1.1× 157 0.5× 227 0.8× 25 0.2× 11 0.1× 48 969
Liang Dong China 16 605 1.0× 112 0.4× 86 0.3× 44 0.4× 9 0.1× 41 857
Federico Monczor Argentina 18 512 0.8× 157 0.5× 32 0.1× 283 2.4× 26 0.3× 43 1.1k

Countries citing papers authored by Eric A. Ertel

Since Specialization
Citations

This map shows the geographic impact of Eric A. Ertel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Ertel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Ertel more than expected).

Fields of papers citing papers by Eric A. Ertel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Ertel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Ertel. The network helps show where Eric A. Ertel may publish in the future.

Co-authorship network of co-authors of Eric A. Ertel

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Ertel. A scholar is included among the top collaborators of Eric A. Ertel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Ertel. Eric A. Ertel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marchesin, Valentina, Peter Blattmann, Florent Chevillard, et al.. (2024). A uniquely efficacious type of CFTR corrector with complementary mode of action. Science Advances. 10(9). eadk1814–eadk1814. 5 indexed citations
2.
Meyer, Emmanuel A., Andrew L. Croxford, Carmela Gnerre, et al.. (2024). Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases. Journal of Medicinal Chemistry. 67(10). 8077–8098. 4 indexed citations
3.
Meyer, Emmanuel A., Eric A. Ertel, Daniel S. Strasser, et al.. (2023). Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies. Journal of Medicinal Chemistry. 66(6). 4179–4196. 6 indexed citations
4.
5.
Roch, Catherine, et al.. (2017). Discovery and evaluation of Cav3.2-selective T-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters. 27(23). 5326–5331. 5 indexed citations
6.
Roch, Catherine, et al.. (2017). Discovery and evaluation of Cav3.1-selective T-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters. 27(23). 5322–5325. 4 indexed citations
7.
Panchaud, Philippe, Thierry Bruyère, Daniel Bur, et al.. (2017). Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents. Journal of Medicinal Chemistry. 60(9). 3755–3775. 80 indexed citations
8.
Siegrist, Romain, Davide Pozzi, Olivier Corminboeuf, et al.. (2017). Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies. Journal of Medicinal Chemistry. 60(23). 9769–9789. 44 indexed citations
9.
10.
Bénardeau, Agnès, et al.. (2000). Effects of the T-Type Ca2+ Channel Blocker Mibefradil on Repolarization of Guinea Pig, Rabbit, Dog, Monkey, and Human Cardiac Tissue. Journal of Pharmacology and Experimental Therapeutics. 292(2). 561–575. 22 indexed citations
11.
Smith, McHardy M., Vivien A. Warren, Richard M. Brochu, et al.. (2000). Nodulisporic Acid Opens Insect Glutamate-Gated Chloride Channels:  Identification of a New High Affinity Modulator. Biochemistry. 39(18). 5543–5554. 53 indexed citations
12.
Clozel, Jean‐Paul, Eric A. Ertel, & Sylvie I. Ertel. (1999). Voltage‐Gated T‐Type Ca2+Channels and Heart Failure. PubMed. 111(5). 429–437. 42 indexed citations
13.
Ertel, Sylvie I. & Eric A. Ertel. (1997). Low-voltage-activated T-type Ca2+ channels. Trends in Pharmacological Sciences. 18(2). 37–42. 72 indexed citations
14.
Clozel, Jean‐Paul, Eric A. Ertel, & Sylvie I. Ertel. (1997). Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. Journal of Hypertension. 15(5). S17–S26. 114 indexed citations
15.
Ertel, Sylvie I., Eric A. Ertel, & Jean‐Paul Clozel. (1997). T-Type Ca2+ Channels and Pharmacological Blockade: Potential Pathophysiological Relevance. Cardiovascular Drugs and Therapy. 11(6). 723–739. 102 indexed citations
16.
Ertel, Eric A., Vivien A. Warren, Michael E. Adams, et al.. (1994). Type III .omega.-Agatoxins: A Family of Probes for Similar Binding Sites on L- and N-Type Calcium Channels. Biochemistry. 33(17). 5098–5108. 36 indexed citations
17.
Ertel, Eric A., McHardy M. Smith, Mark D. Leibowitz, & Charles J. Cohen. (1994). Isolation of myocardial L-type calcium channel gating currents with the spider toxin omega-Aga-IIIA.. The Journal of General Physiology. 103(5). 731–753. 14 indexed citations
18.
Ertel, Eric A.. (1994). Modulation of guanylate cyclase and phosphodiesterase by monovalent cations and nucleoside triphosphates in light-sensitive excised patches of rod outer segments. Pflügers Archiv - European Journal of Physiology. 428(3-4). 372–381. 2 indexed citations
19.
Ertel, Eric A. & Charles J. Cohen. (1994). Voltage‐dependent interactions: The influence and significance of membrane potential on drug‐receptor interactions. Drug Development Research. 33(3). 203–213. 7 indexed citations
20.
Cohen, Charles J., Eric A. Ertel, McHardy M. Smith, et al.. (1992). High affinity block of myocardial L-type calcium channels by the spider toxin omega-Aga-toxin IIIA: advantages over 1,4-dihydropyridines.. Molecular Pharmacology. 42(6). 947–951. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory H. Hockerman Breakdown of academic impact, for papers by Donald H. Jenkinson Breakdown of academic impact, for papers by Theresa A. Kuntzweiler Breakdown of academic impact, for papers by László Kovács Breakdown of academic impact, for papers by Jon T. Sack Breakdown of academic impact, for papers by Jeff S. McDermott Breakdown of academic impact, for papers by K Gietzen Breakdown of academic impact, for papers by Francisco Fernández-Belda Breakdown of academic impact, for papers by Liang Dong Breakdown of academic impact, for papers by Federico Monczor
Rankless by CCL
2026